Skip to content

Rapid Therapeutic Science Laboratories, Inc.: filings

Every Rapid Therapeutic Science Laboratories, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 30 filings, each linked to its SEC index.

Filing record ends 2023-08-14

The latest filing in this captured record is a 10-Q filed 2023-08-14. No later filing is in the SEC companyfacts record captured on 2026-09-22. Rapid Therapeutic Science Laboratories, Inc. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2023-08-14fiscal Q2 202334950001393905-23-000312
10-Q2023-05-12fiscal Q1 202333670001393905-23-000220
10-K2023-03-30fiscal FY 202236720001393905-23-000156
10-Q2022-11-10fiscal Q3 2022351030001393905-22-000447
10-Q2022-08-12fiscal Q2 202235990001393905-22-000302
10-Q2022-05-11fiscal Q1 202234690001393905-22-000151
10-K2022-03-16fiscal FY 202135710001393905-22-000069
10-Q2021-11-10fiscal Q3 202132960001393905-21-000494
10-Q2021-08-11fiscal Q2 202131900001393905-21-000369
10-Q2021-05-14fiscal Q1 202131660001393905-21-000251
10-Q2020-11-09fiscal Q2 202133940001393905-20-000316
10-Q2020-08-13fiscal Q1 202128600001393905-20-000237
10-K2020-06-29fiscal FY 202028570001393905-20-000203
10-Q2020-03-31fiscal Q3 202025840001393905-20-000093
10-Q2019-11-05fiscal Q2 202022620001393905-19-000305
10-Q2019-07-26fiscal Q1 202022480001393905-19-000234
10-K2019-07-09fiscal FY 201927560001393905-19-000220
10-Q2019-02-14fiscal Q3 201923600001393905-19-000049
10-Q2019-01-15fiscal Q2 201923600001393905-19-000022
10-Q2019-01-15fiscal Q1 201923480001393905-19-000020
10-K2018-12-06fiscal FY 201828580001393905-18-000353
10-Q2018-01-29fiscal Q3 201818450001393905-18-000024
10-Q2017-11-07fiscal Q2 201818470001393905-17-000338
10-Q2017-08-10fiscal Q1 201817360001393905-17-000227
10-K2017-07-14fiscal FY 201718370001393905-17-000206
10-Q2017-02-01fiscal Q3 201718460001393905-17-000019
10-Q2016-10-13fiscal Q2 201718460001393905-16-001058
10-Q2016-08-15fiscal Q1 201717360001393905-16-001004
10-K2016-06-17fiscal FY 201618320001393905-16-000952
10-Q2016-02-04fiscal Q3 201613380001393905-16-000715

Inspect the source

Entity
Rapid Therapeutic Science Laboratories, Inc. / CIK 0001575659
Captured
SEC response SHA-256
14c2f9b3bc7d0f13fd632270204844e50b85735a1f8bf5f498879de490e92d11

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001575659.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))